DKRT Investments’s Biogen BIIB Stock Holding History

DKRT Investments’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$540K	Hold	2,500	–	–	0.13%	41
2026 Q1	$458K	Hold	2,500	–	–	0.12%	39
2025 Q4	$440K	Hold	2,500	–	–	0.12%	38
2025 Q3	$350K	Hold	2,500	–	–	0.08%	39
2025 Q2	$314K	Buy	+2,500	New	+$312K	0.08%	37

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DKRT Investments's BIIB Position: Q2 2026 in Review

DKRT Investments held its Biogen (BIIB) position steady in Q2 2026 at 2,500 shares worth $540K. The position accounts for 0.13% of the portfolio, ranked #41.

DKRT Investments first reported a position in BIIB in Q2 2025 and has held it in 5 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

DKRT Investments held 2,500 shares of Biogen worth $540K as of Q2 2026.
DKRT Investments left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.13% of DKRT Investments's portfolio in Q2 2026, its #41 holding.
DKRT Investments first reported a position in Biogen in Q2 2025 and has held it in 5 quarters since.
1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on DKRT Investments's 13F filing for Q2 2026, filed 13 Aug 2026.